Rox Medical said today that it raised a $40 million Series E round for the stent-like Coupler device it developed to treat hypertension by connecting the femoral artery and the femoral vein. The round was led by the Novartis Venture Fund and Apple Tree Partners, with participation from prior backers Versant Ventures and Domain Associates, San Clemente, Calif.-based Rox said. […]
Funding Roundup
FDA nod for Angel catheter triggers $3m tranche for Bio2 Medical
The 510(k) clearance Bio2 Medical won from the FDA in July for its Angel catheter triggered a 2nd, $3 million tranche from Oxford Finance last week, the company said yesterday. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to […]
Rivanna Medical pulls down $3m
Rivanna Medical, which makes an epidural needle guidance device, raised $3 million in an equity offering, according to a regulatory filing. Charlottesville, Va.-based Rivanna won 510(k) clearance from the FDA for its Accuro handheld needle guidance device indicated for spinal anesthesia in March 2015 and launched the device last November. A quintet of unnamed investors participated in […]
Opko Health gets in on BioCardia after merger with Tiger X Medical
BioCardia said today that Opko Health (NYSE:OPK) agreed to pick up a “significant” stake in its business after a merger with Tiger X Medical (OTC:CDOM). The new company will keep the BioCardia name and the development program for its CardiAMP cell therapy for heart failure patient’s who’ve had a heart attack. Stem cells derived from the bone marrow of […]
ViewRay raises $14m in private placement
ViewRay (NSDQ:VRAY) said today that it raised nearly $14 million in a private placement as it gears up to launch its MRIdian linear accelerator, saying it expects to win regulatory nods in the U.S. and overseas by the end of the year. Cleveland-based ViewRay said the round was led by existing backers OrbiMed Advisors, Xeraya Capital and Kearny Venture […]
ReVision Optics takes out $10m credit line for Raindrop inlay
ReVision Optics said today that it took out a $10 million credit line with Pacific Western Bank subsidiary Square 1 Bank as it looks to build out its commercial operation after winning FDA approval for its Raindrop presbyopia inlay. The Raindrop inlay, a corneal implant designed to treat nearsightedness, won pre-market approval from the FDA in June. […]
Medpace IPO drums up $185m
Contract research organization Medpace (NSDQ:MEDP) said yesterday that its initial public offering closed after raising more than $185 million, including an underwriter’s over-allotment that added more than $24 million to the IPO. Cincinnati-based Medpace said it floated 8.05 million shares at $23 apiece, including the 1.05-million-share over-allotment, netting about $173.6 million for the CRO. The proceeds are earmarked […]
Rotation Medical adds $12m to Series B for regenerative rotator cuff treatment
Rotation Medical said today that it added $12 million to a Series B round that’s already brought in $27 million. Plymouth, Minn.-based Rotation makes a regenerative treatment for repairing the shoulder’s rotator cuff – a group of muscles and tendons that attach the humerus to the scapula. The system won 510(k) clearance in March 2014. The company said existing […]
Outside developers suspend Sport medical ‘bot program until Titan Medical can pay its bills
The product developers Titan Medical (CVE:TMD) hired to help create its Sport robot-assisted surgery platform have suspended development until the company can cover its bills, and $16 million in financing from a Chinese private equity firm might not happen after all, Titan said yesterday. The Toronto-based company said its product developers “have decided to temporarily suspend development […]
Mazor X unveiling triggers another $20m from Medtronic
Mazor Robotics (NSDQ:MZOR) said today that the unveiling last month of its Mazor X robot-assisted spine surgery platform triggered the 2nd step in a 3-stage equity deal with Medtronic (NYSE:MDT). Medtronic paid $20 million for a 3.4% stake in Mazor at $21.84 apiece, the trailing 20-day average for MZOR shares, the Caesarea, Israel-based company said. It’s part of a 2-stage deal […]
Avinger prices $30m follow-on offering
Avinger (NSDQ:AVGR) today priced a follow-on offering worth $30 million, saying it plans to dip into the cash if it needs to cover penalties for missed revenue covenants this year. Redwood City, Calif.-based Avinger said it plans to float nearly 8.6 million shares at $3.50 apiece, plus a possible 1.3-million-share underwriters over-allotment that could bring in another […]